ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Initial investigations have established an association between increased serum concentrations of ANGPTL8 and NAFLD and its severity (von Loeffelholz et al., 2017; Lee et al., 2016; Cengiz et al., 2016).